agilon health, inc. (AGL)
Pre-market:
| Previous close | 3.3200 |
| Open | 3.3000 |
| Bid | 3.0500 x 4000 |
| Ask | 3.3800 x 4000 |
| Day's range | 3.1150 - 3.3400 |
| 52-week range | 2.9950 - 20.3700 |
| Volume | |
| Avg. volume | 4,388,721 |
| Market cap | 1.325B |
| Beta (5Y monthly) | 0.54 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
agilon health to Participate at 2024 Wells Fargo Healthcare Conference
AUSTIN, Texas, August 21, 2024--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will participate in the 2024 Wells Fargo Healthcare Conference, including a fireside chat presentation on Wednesday, September 4, at 3:00 PM Eastern Time.
- Business Wire
agilon health Reports Second Quarter 2024 Results
AUSTIN, Texas, August 06, 2024--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced results for the second quarter ended June 30, 2024.
- Business Wire
agilon health Sets Date to Report Second Quarter 2024 Financial Results
AUSTIN, Texas, July 23, 2024--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the second quarter 2024 after the market closes on Tuesday, August 6, 2024, and host a conference call at 4:30 PM Eastern Time the same day to discuss the results.
